LPAR5 and non-small cell lung carcinoma: In KRAS-TP53 mutant non-small cell lung cancer, autotaxin and LPA are markedly upregulated in tumors resistant to anti-PD-1 therapy, where they suppress CD8+ T cell infiltration via LPAR5 signaling [53].